The burden of psoriasis in Canada: Insights from the pSoriasis Knowledge IN Canada (SKIN) survey

Journal of Cutaneous Medicine and Surgery

Volumn 13, Issue 5, 2009, Pages 235-252

  Lynde, Charles W ^a,b,c,d   Poulin, Yves ^a,b,c,d   Guenther, Lyn ^a,b,c,d   Jackson, Christine ^a,b,c,d  

^a Lynde Centre for Dermatology Canada   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Guenther Dermatology Research Centre   (Canada)

^d Canadian Skin Patient Alliance   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; BODY SURFACE; CANADA; COMORBIDITY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SELF REPORT; SKIN DEFECT;

ACTIVITIES OF DAILY LIVING; ADULT; CANADA; FEMALE; HUMANS; MALE; MORBIDITY; PATIENT EDUCATION AS TOPIC; POPULATION SURVEILLANCE; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 70350545962     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2009.08071     Document Type: Article

References (43)

1. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996;14:485-96.
2. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263-71.
3. Griffiths CE, Christophers E, Barker JN, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007;156: 258-62.
4. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1-18.
5. Ciocon DH, Horn EJ, Kimball AB. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 spring US National Psoriasis Foundation survey. Am J Clin Dermatol 2008;9: 111-7.
6. Furfaro N. Diagnostic signs and symptoms of psoriatic arthritis. Dermatol Nurs 2006;Suppl:7-9, 22.
7. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573.
8. Gottlieb AB, Mease PJ, Jackson JM, et al. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices. J Dermatolog Treat 2006;17:279-87.
9. Schmitt J, Ford DE. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach. Gen Hosp Psychiatry 2007;29:134-40.
10. Horn EJ, Fox KM, Patel V, et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol 2007;57:957-62.
11. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
12. Nijsten T, Rolstad T, Feldman SR, et al. Members of the National Psoriasis Foundation: more extensive disease and better informed about treatment options. Arch Dermatol 2005;141:19-26.
13. Thomas CL, Finlay AY. The 'handprint' approximates to 1% of the total body surface area whereas the 'palm minus the fingers' does not. Br J Dermatol 2007;157:1080-1.
14. Kirby B, Richards HL, Mason DL, et al. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008;158:138-40.
15. Gelfand JM, Feldman SR, Stern R, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004;51:704-8.
16. Bhosle MJ, Kulkarni A, Feldman SR, et al. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35.
17. Gelfand JM, Stern R, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005;52:23-6.
18. Horn EJ, Fox KM, Patel V, et al. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007;57:963-71.
19. Nijsten T, Margolis DJ, Feldman SR, et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results froma national survey. J Am Acad Dermatol 2005;52(3 Pt 1), 434-44.
20. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007;167:1670-5.
21. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136-9.
22. Borman P, Toy GG, Babaoǧlu S, et al. A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis. Clin Rheumatol 2007;26:330-4.
23. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
24. Opmeer BC, Heydendaelb VMR, de Borgie CAJM, et al. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions. J Clin Epidemiol 2007;60:696-703.
25. Roelofzen JH, Aben KKH, Khawarl AJM, et al. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders. Eur J Dermatol 2007;17:416-21.
26. Schoffski O, Augustin M, Prinz J, et al. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study. J Dtsch Dermatol Ges 2007;5:209-18.
27. Altobelli E, Maccarone M, Petrocelli R, et al. Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population. BMC Public Health 2007;7:59.
28. Dubertret L, Mrowietz U, Ranki A, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006;155:729-36.
29. Ferrandiz C, Pujol RM, Garcia-Patos V, et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002;46:867-73.
30. Finzi AF, Benelli C. A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis. J Eur Acad Dermatol Venereol 1998;10:125-9.
31. Scarpa R, Oriente P, Pucino A, et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984;23:246-50.
32. Wahl A, Loge JH, Wiklund I, et al. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 2000;43(5 Pt 1):803-8.
33. Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002;82:108-13.
34. Leczinsky CG. The incidence of arthropathy in a 10 year series of psoriasis cases. Acta Derm Venereol 1948;28:483-7.
35. Elkayam O, Ophir J, Yaron M, et al. Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 2000;19:301-5.
36. Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 1999;26:1752-6.
37. Heydendael VM, de Borgie CAJM, Spuls PJ, et al. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc 2004;9:131-5.
38. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002;47:512-8.
39. Richards HL, Fortune DG, Griffiths CE, et al. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001;50:11-5.
40. Schmid-Ott G, Schallmayer S, Calliess IT. Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience. Clin Dermatol 2007;25:547-54.
41. Schmitt JM, Ford DE. Role of depression in quality of life for patients with psoriasis. Dermatology 2007;215:17-27.
42. Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;59: 209-17.
43. Feldman SR, Fleischer AB, Reboussin DM, et al. The self-administered Psoriasis Area and Severity Index is valid and reliable. J Invest Dermatol 1996;106:183-6.